Morgan Stanley Equalweight on MedAssets

Morgan Stanley is out with a research report on MedAssets Inc. MDAS and it has a Equal-Weight rating on shares. In a note to clients, Morgan Stanley writes, "MedAssets reported strong 3Q11 results due largely to ~$3.0 mil (~$0.03/share after-tax) of milestone performance payments from the Texas Purchasing Coalition expected in 4Q being accelerated into 3Q. Revenues of $143.7 mil exceeded MS of $137.3 mil and consensus of $137.4 mil, and adjusted EPS of $0.26 well exceeded MS and consensus of $0.16 even after the ~$0.03 benefit of a lower tax rate." Shares of MDAS lost 40 cents yesterday to close at $10.36.